Schizophrenia & Other Psychotic Disorders
Latest News
The DEA Plans to Reschedule Marijuana: What Happens Next?
Following 2023 FDA information that legitimized marijuana as a medical treatment, DEA moves to lower its scheduling.
Latest News
Most Homeless People Have Mental Health Disorders
The current prevalence of mental health disorders among people experiencing homelessness was 67% and the lifetime prevalence was 77%.
Latest News
Childhood Loneliness Predictive of Subsequent Psychosis?
In those who did not have objective social isolation in childhood, loneliness was associated with a significantly increased risk for first-episode...
Latest News
Early Evidence Supports Ketogenic Diet for Mental Illness
New research indicates psychiatric illness may be linked to brain metabolism, and a keto diet may offer protection.
Latest News
Probiotic–Vitamin D Combo May Boost Cognition in Schizophrenia
The combination also led to favorable changes in total cholesterol, fasting blood sugar, and a marker of inflammation.
Latest News
High-Dose Valproate Linked to Significant Weight Gain
Each 500-mg increase in valproate dose was associated with a weight increase of 0.52% per month over a year.
Latest News
Clozapine Underutilized in Black Patients With Schizophrenia
Underprescription of clozapine in Black patients with schizophrenia may include concerns about prescriber bias, prescribers’ anticipation of...
Latest News
New Insight Into ‘Demon’ Facial Visual Perception Disorder
Researchers create images that depict PMO, a condition causing visual distortion of faces.
Latest News
Long-Acting Injectable Antipsychotics Reduce Schizophrenia Readmission
Study suggests patients who receive LAI antipsychotics were far less commonly readmitted within 30 days.
Latest News
Number of State Psychiatric Hospital Beds Hits Historic Low
Based on a recent study, the number of psychiatric hospital beds is about 11 per 100,000 people.
From the Journals
Schizophrenia Med Safe, Effective for Bipolar Mania: Phase 3 Data
Iloperidone was first approved by the US Food and Drug Administration in 2009 for treatment of schizophrenia.